StemBioSys is a privately held biotechnology company whose technologies represent the next evolution in cell research. Products are branded under the CELLvo™ name.
The centerpiece of these technologies is CELLvo™ Matrix. This cell-derived microenvironment allows a variety of cells to replicate more rapidly, maintain phenotype over multiple passages and express markers indicative of potency beyond that seen with traditional tissue culture substrates. The company also manufactures several cell products isolated and expanded on our matrix.
Our suite of products promote confidence in preclinical safety and drug toxicity screening and StemBioSys will continue to develop solutions that simply scientific progress.